Proton Pump Inhibitors Linked to Non-Specific Gastric Inflammation in Children

Published Online: Monday, June 9, 2014
Follow Pharmacy_Times:
An increased risk of non-specific gastric inflammation is found in children exposed to PPIs for more than 6 weeks.

Exposure to proton pump inhibitors (PPIs) is associated with non-specific gastric inflammation (NSGI) in children, according to a study published in Pediatric Gastroenterology and Hepatology on January 20, 2014. The risk increases if the patient is exposed to a PPI for a period greater than 6 weeks, and significantly increased after 3 months.

For their study, Eduardo Rosas-Blum and colleagues at the University of Texas reviewed 310 endoscopy and biopsy reports of patients who underwent an esophagogastroduodenoscopy between July 2009 and July 2010.

To read the rest of this article, click here.
Related Articles
An early introduction to peanuts may help prevent nut allergies among children, according to a new study published in The New England Journal of Medicine.
Gastroesophageal reflux disease and atrial fibrillation are 2 of the most significant health concerns in the United States, and researchers suspect a link between them.
The FDA today approved a supplemental New Drug Application for Eisai’s rufinamide (Banzel) as an adjunctive treatment for seizures associated with Lennox-Gastaut Syndrome in pediatric patients aged 1 to 4 years.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$